Results 201 to 210 of about 1,141,588 (254)
Serum bilirubin as a biomarker of oxidative stress in children with type 1 diabetes mellitus: An observational study. [PDF]
Medicine (Baltimore)Wei J, Wei J, Yu X, Xie J, Chen X.
europepmc +1 more source
Case Report: SARS-CoV-2-associated immune dysfunction manifesting as concurrent fulminant type 1 diabetes mellitus and subacute thyroiditis. [PDF]
Front Med (Lausanne)Fang W, Wang H, Zhong L, Xu J, Zhu H.
europepmc +1 more source
Clinical use and monitoring of adverse effects of sodium-glucose cotransporter-2 inhibitors in persons with type 1 diabetes mellitus. [PDF]
J Diabetes InvestigSakai C +4 more
europepmc +1 more source
Sequential development of hyperinsulinemic hypoglycemia and type 1 diabetes mellitus in a male child with trisomy 13. [PDF]
Endocrinol Diabetes Metab Case RepSugimoto S +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Yearbook of Paediatric Endocrinology, 2018
Type 1 diabetes mellitus is a heterogeneous metabolic disease characterized by destruction of the pancreatic beta cells resulting in an absolute deficiency of insulin secretion with subsequent hyperglycemia. This review details the definition and classification, epidemiology, pathophysiology, pathogenesis, prevention, diagnosis, and management of type ...
Wieland Kiess +2 more
openaire +3 more sources
Type 1 diabetes mellitus is a heterogeneous metabolic disease characterized by destruction of the pancreatic beta cells resulting in an absolute deficiency of insulin secretion with subsequent hyperglycemia. This review details the definition and classification, epidemiology, pathophysiology, pathogenesis, prevention, diagnosis, and management of type ...
Wieland Kiess +2 more
openaire +3 more sources
Pediatrics In Review, 2013
1. Justin M. Gregory, MD* 2. Daniel J. Moore, MD, PhD† 3. Jill H. Simmons, MD‡ 1. *Pediatric Endocrinology Clinical Fellow, Ian Burr Division of Pediatric Endocrinology and Diabetes, Vanderbilt University School of Medicine, Nashville, TN. 2.
Justin M. Gregory +2 more
openaire +3 more sources
1. Justin M. Gregory, MD* 2. Daniel J. Moore, MD, PhD† 3. Jill H. Simmons, MD‡ 1. *Pediatric Endocrinology Clinical Fellow, Ian Burr Division of Pediatric Endocrinology and Diabetes, Vanderbilt University School of Medicine, Nashville, TN. 2.
Justin M. Gregory +2 more
openaire +3 more sources
Annals of Internal Medicine, 2022
Type 1 diabetes mellitus (T1DM) is an endocrine disorder in which pancreatic β cells stop producing insulin, typically due to autoimmune destruction. This results in hyperglycemia and ketosis; thus, insulin replacement is vital to management. Incidence peaks in puberty and early adulthood, but onset can occur at any age.
openaire +2 more sources
Type 1 diabetes mellitus (T1DM) is an endocrine disorder in which pancreatic β cells stop producing insulin, typically due to autoimmune destruction. This results in hyperglycemia and ketosis; thus, insulin replacement is vital to management. Incidence peaks in puberty and early adulthood, but onset can occur at any age.
openaire +2 more sources
Nature Reviews Disease Primers, 2017
Type 1 diabetes mellitus (T1DM), also known as autoimmune diabetes, is a chronic disease characterized by insulin deficiency due to pancreatic β-cell loss and leads to hyperglycaemia. Although the age of symptomatic onset is usually during childhood or adolescence, symptoms can sometimes develop much later.
Laura M. Jacobsen +8 more
openaire +3 more sources
Type 1 diabetes mellitus (T1DM), also known as autoimmune diabetes, is a chronic disease characterized by insulin deficiency due to pancreatic β-cell loss and leads to hyperglycaemia. Although the age of symptomatic onset is usually during childhood or adolescence, symptoms can sometimes develop much later.
Laura M. Jacobsen +8 more
openaire +3 more sources